Timothy P. Walbert
CIK: 0001349376
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 17, 2026KARD
Kardigan, Inc.
Award(A)Direct20.7K shares- - Jun 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
3.8K shares- - Jun 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
2K shares- - Jun 2, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct7.5K shares- - May 29, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct4K shares- - May 7, 2026ODTX
Odyssey Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
27.4K shares- - Jun 12, 2025IPSC
Century Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
44K shares- - Jun 9, 2025SGMT
Sagimet Biosciences Inc.
Award(A)DirectStock Option (Right to Buy)
32.3K shares- - May 29, 2025MIRM
Mirum Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
4K shares- - May 29, 2025MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct5.7K shares- - May 29, 2025MIRM
Mirum Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
6.3K shares- - May 20, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct6.7K shares- - Feb 24, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct3.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  KARD Kardigan, Inc. | Award(A) | 20,706 | - | $0 | Direct |
| Jun 15, 2026 |  MIRM Mirum Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 3,772 | - | - | Direct |
| Jun 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 1,980 | - | - | Direct |
| Jun 2, 2026 |  BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 7,490 | - | $0 | Direct |
| May 29, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 3,977 | - | $0 | Direct |
| May 7, 2026 |  ODTX Odyssey Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 27,393 | - | - | Direct |
| Jun 12, 2025 |  IPSC Century Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 44,000 | - | - | Direct |
| Jun 9, 2025 |  SGMT Sagimet Biosciences Inc. | Award(A) Stock Option (Right to Buy) | 32,250 | - | - | Direct |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 3,977 | - | - | Direct |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 5,703 | - | - | Direct |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 6,268 | - | - | Direct |
| May 20, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 6,650 | - | - | Direct |
| Feb 24, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 3,130 | - | - | Direct |
1-13 of 13 transactions
About Walbert Timothy P
Walbert Timothy P (SEC CIK 0001349376) files insider reports with the SEC as Director of Latigo Biotherapeutics, Inc. (LTGO), Director of Kardigan, Inc. (KARD) and Director of Mirum Pharmaceuticals, Inc. (MIRM). Signal8 also holds filings tied to 4 other companies.
Signal8 holds 15 ownership filings by Walbert Timothy P (5 Form 3, 10 Form 4), filed between Feb 26, 2025 and Aug 6, 2026. Those filings report 13 transactions, from Feb 24, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Walbert Timothy P's filings is in FOSTER CITY, CA.
Recent filings by Walbert Timothy P
- Jun 17, 2026: Grant or award of KARD shares (Form 4, code A).
- Jun 15, 2026: Grants or awards of MIRM derivative securities (2 lines, Form 4, code A).
- Jun 2, 2026: Grant or award of BMRN shares (Form 4, code A).
- May 29, 2026: Option exercise of MIRM shares (Form 4, code M).
- May 7, 2026: Grant or award of ODTX derivative securities (Form 4, code A).
Other insiders filing for Latigo Biotherapeutics, Inc. (LTGO)
- 5AM Ventures VI, L.P., 10% Owner
- Sanofi, 10% Owner
- Westlake BioPartners Fund I, L.P., 10% Owner
- Foresite Capital Management V, LLC, 10% Owner
- SMITH TODD N, Director
- Tananbaum James B., Director